Additional remetinostat phase II data will be presented at the International Investigative Dermatology meeting on May 18 and 19Read more
Resolutions at the Annual General Meeting in Medivir on 3 May 2018Read more
Number of shares and votes in MedivirRead more
Quarterly report presentations
Medivir Corporate Governance documention.
Documentation from Medivir's Annual General Meetings.